Cargando…

Factors Influencing Background Incidence Rate Calculation: Systematic Empirical Evaluation Across an International Network of Observational Databases

Objective: Background incidence rates are routinely used in safety studies to evaluate an association of an exposure and outcome. Systematic research on sensitivity of rates to the choice of the study parameters is lacking. Materials and Methods: We used 12 data sources to systematically examine the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ostropolets, Anna, Li, Xintong, Makadia, Rupa, Rao, Gowtham, Rijnbeek, Peter R., Duarte-Salles, Talita, Sena, Anthony G., Shaoibi, Azza, Suchard, Marc A., Ryan, Patrick B., Prieto-Alhambra, Daniel, Hripcsak, George
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9087898/ https://www.ncbi.nlm.nih.gov/pubmed/35559254 http://dx.doi.org/10.3389/fphar.2022.814198

Ejemplares similares

Characterizing the incidence of adverse events of special interest for COVID-19 vaccines across eight countries: a multinational network cohort study
por: Li, Xintong, et al.
Publicado: (2021)

Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study
por: Li, Xintong, et al.
Publicado: (2021)

Bias, Precision and Timeliness of Historical (Background) Rate Comparison Methods for Vaccine Safety Monitoring: An Empirical Multi-Database Analysis
por: Li, Xintong, et al.
Publicado: (2021)

Evaluating the impact of alternative phenotype definitions on incidence rates across a global data network
por: Makadia, Rupa, et al.
Publicado: (2023)

Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort Study
por: Shoaibi, Azza, et al.
Publicado: (2022)

Heterologous vaccine regimens against COVID-19
por: Duarte-Salles, Talita, et al.
Publicado: (2021)

Vaccine Safety Surveillance Using Routinely Collected Healthcare Data—An Empirical Evaluation of Epidemiological Designs
por: Schuemie, Martijn J., et al.
Publicado: (2022)

Corrigendum: Vaccine safety surveillance using routinely collected healthcare data—An empirical evaluation of epidemiological designs
por: Schuemie, Martijn J., et al.
Publicado: (2022)

Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study
por: Burn, Edward, et al.
Publicado: (2022)

Characteristics and outcomes of COVID-19 patients with COPD from the United States, South Korea, and Europe
por: Moreno-Martos, David, et al.
Publicado: (2023)

Comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with different covid-19 vaccines: international network cohort study from five European countries and the US
por: Li, Xintong, et al.
Publicado: (2022)

Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in Catalonia, Spain
por: Burn, Edward, et al.
Publicado: (2022)

Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2 in the United Kingdom
por: Burn, Edward, et al.
Publicado: (2022)

Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study
por: Lane, Jennifer C E, et al.
Publicado: (2020)

Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance
por: Arshad, Faaizah, et al.
Publicado: (2023)

Alpha-1 blockers and susceptibility to COVID-19 in benign prostate hyperplasia patients : an international cohort study
por: Nishimura, Akihiko, et al.
Publicado: (2021)

International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients
por: Nishimura, Akihiko, et al.
Publicado: (2022)

Transforming the Premier Perspective® Hospital Database into the Observational Medical Outcomes Partnership (OMOP) Common Data Model
por: Makadia, Rupa, et al.
Publicado: (2014)

Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study
por: Voss, Erica A., et al.
Publicado: (2023)

Socioeconomic Inequalities in COVID-19 Vaccination and Infection in Adults, Catalonia, Spain
por: Roel, Elena, et al.
Publicado: (2022)

Evaluating a novel approach to stimulate open science collaborations: a case series of “study-a-thon” events within the OHDSI and European IMI communities
por: Hughes, N, et al.
Publicado: (2022)

COVID-19 vaccination effectiveness rates by week and sources of bias
por: Ostropolets, Anna, et al.
Publicado: (2021)

COVID-19 vaccination effectiveness rates by week and sources of bias: a retrospective cohort study
por: Ostropolets, Anna, et al.
Publicado: (2022)

Robust empirical calibration of p‐values using observational data
por: Schuemie, Martijn J., et al.
Publicado: (2016)

Methotrexate and relative risk of dementia amongst patients with rheumatoid arthritis: a multi-national multi-database case-control study
por: Newby, Danielle, et al.
Publicado: (2020)

Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus (LEGEND-T2DM): a protocol for a series of multinational, real-world comparative cardiovascular effectiveness and safety studies
por: Khera, Rohan, et al.
Publicado: (2022)

Improving reproducibility by using high-throughput observational studies with empirical calibration
por: Schuemie, Martijn J., et al.
Publicado: (2018)

Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis
por: Li, Xintong, et al.
Publicado: (2022)

Implementation of the COVID-19 Vulnerability Index Across an International Network of Health Care Data Sets: Collaborative External Validation Study
por: Reps, Jenna M, et al.
Publicado: (2021)

Seek COVER: using a disease proxy to rapidly develop and validate a personalized risk calculator for COVID-19 outcomes in an international network
por: Williams, Ross D., et al.
Publicado: (2022)

Drug Utilisation Patterns of Alternatives to Ranitidine-Containing Medicines in Patients Treated with Ranitidine: A Network Analysis of Data from Six European National Databases
por: Arinze, Johnmary T., et al.
Publicado: (2023)

Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four European cohorts
por: Alexander, Myriam, et al.
Publicado: (2019)

A standardized analytics pipeline for reliable and rapid development and validation of prediction models using observational health data
por: Khalid, Sara, et al.
Publicado: (2021)

Body mass index and risk of COVID-19 diagnosis, hospitalisation, and death: a cohort study of 2 524 926 Catalans
por: Recalde, Martina, et al.
Publicado: (2021)

Current Approaches to Vaccine Safety Using Observational Data: A Rationale for the EUMAEUS (Evaluating Use of Methods for Adverse Events Under Surveillance-for Vaccines) Study Design
por: Lai, Lana YH, et al.
Publicado: (2022)

Characterizing physicians’ information needs related to a gap in knowledge unmet by current evidence
por: Ostropolets, Anna, et al.
Publicado: (2020)

Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study
por: Lane, Jennifer C E, et al.
Publicado: (2020)

The natural history of symptomatic COVID-19 during the first wave in Catalonia
por: Burn, Edward, et al.
Publicado: (2021)

Characterizing Anchoring Bias in Vaccine Comparator Selection Due to Health Care Utilization With COVID-19 and Influenza: Observational Cohort Study
por: Ostropolets, Anna, et al.
Publicado: (2022)

Real-world data reveal a diagnostic gap in non-alcoholic fatty liver disease
por: Alexander, Myriam, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_eta8m73r16a30q7io1mm08uet0